Rosenberg Matthew Hamilton Purchases 31 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Rosenberg Matthew Hamilton increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 878 shares of the healthcare conglomerate’s stock after purchasing an additional 31 shares during the quarter. Rosenberg Matthew Hamilton’s holdings in UnitedHealth Group were worth $514,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. WFA Asset Management Corp raised its stake in shares of UnitedHealth Group by 44.0% in the first quarter. WFA Asset Management Corp now owns 265 shares of the healthcare conglomerate’s stock worth $131,000 after purchasing an additional 81 shares during the last quarter. First Trust Direct Indexing L.P. raised its holdings in UnitedHealth Group by 0.4% during the 1st quarter. First Trust Direct Indexing L.P. now owns 13,820 shares of the healthcare conglomerate’s stock valued at $6,837,000 after buying an additional 54 shares during the period. RBA Wealth Management LLC boosted its position in shares of UnitedHealth Group by 0.9% during the first quarter. RBA Wealth Management LLC now owns 11,785 shares of the healthcare conglomerate’s stock valued at $5,830,000 after buying an additional 109 shares during the period. Core Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 4.0% during the first quarter. Core Wealth Partners LLC now owns 1,044 shares of the healthcare conglomerate’s stock valued at $516,000 after purchasing an additional 40 shares during the period. Finally, Tempus Wealth Planning LLC increased its position in shares of UnitedHealth Group by 47.8% during the first quarter. Tempus Wealth Planning LLC now owns 652 shares of the healthcare conglomerate’s stock worth $322,000 after acquiring an additional 211 shares during the period. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on UNH. Bank of America dropped their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and boosted their price target for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Royal Bank of Canada reduced their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 24th. Finally, TD Cowen raised their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Stock Performance

UNH stock traded up $1.79 during trading on Thursday, hitting $564.75. 356,717 shares of the company traded hands, compared to its average volume of 3,895,572. The company has a market cap of $521.50 billion, a PE ratio of 36.72, a P/E/G ratio of 1.66 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The stock’s 50-day simple moving average is $582.60 and its 200 day simple moving average is $540.48. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm posted $6.56 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.